A5002719578- Substance Abuse Treatment and Outcomes
- Alcoholism and Thiamine Deficiency
- Impact of Technology on Adolescents
- Schizophrenia research and treatment
- Gambling Behavior and Treatments
- Personality Disorders and Psychopathology
- Smoking Behavior and Cessation
- Alcohol Consumption and Health Effects
- Eating Disorders and Behaviors
- Treatment of Major Depression
- Cannabis and Cannabinoid Research
- Digital Mental Health Interventions
- Pharmaceutical Practices and Patient Outcomes
- Health, Medicine and Society
- Healthcare Systems and Practices
- Bipolar Disorder and Treatment
- Prenatal Substance Exposure Effects
- Tryptophan and brain disorders
- Suicide and Self-Harm Studies
- Aging, Elder Care, and Social Issues
- Psychological and Temporal Perspectives Research
- Opioid Use Disorder Treatment
- Genetic Associations and Epidemiology
- High Altitude and Hypoxia
- Diabetes, Cardiovascular Risks, and Lipoproteins
Hôpital Paul-Brousse
2023-2025
Institut de Psychiatrie et Neurosciences de Paris
2019-2025
Electronic Product Services (Czechia)
2025
Centre National de la Recherche Scientifique
2019-2025
Groupe de Recherche sur l'Alcool et les Pharmacodépendances
2018-2024
Université Paris-Saclay
2024
Inserm
2018-2024
Université de Picardie Jules Verne
2018-2024
Assistance Publique – Hôpitaux de Paris
2024
Centre Hospitalier Universitaire Amiens-Picardie
2018-2023
Recreational use and misuse of nitrous oxide (N2O) have increased in recent years among young people. The objective present study was to assess the frequency clinical characteristics N2O disorder (NUD) a sample health professions students. An online survey distributed Age; sex; (day/week/month/year/lifetime) use, DSM-5 criteria for NUD; history mental treatment; current antidepressant medication were systematically collected. All participants completed French version Alcohol Use Disorders...
Abstract Aims To assess recovery of alcohol-related neuropsychological deficits in a group patients with pure severe alcohol use disorder (AUD) during detoxification program using the Brief Evaluation Alcohol-Related Neuropsychological Impairment (BEARNI) test. Methods Thirty-two AUD DSM-IV criteria (24 men, mean age = 45.5 ± 6.8 years old) were assessed BEARNI 8 2 days after cessation (T1) and then reassessed within 18 (T2). The primary study endpoint was number initially impaired at T1 who...
Abstract Purpose of Review Gamma-hydroxybutyrate (GHB) is an illicit drug used for many reasons: during music festivals or parties, self-management sleep and anxiety, in combination with other drugs to facilitate chemsex. Most people who use GHB do so occasionally, without harm. However, a minority users experience dependence withdrawal symptoms. syndrome often has specific course, rapid onset swift progression severe complications. In this narrative review, we aimed summarize recent...
AbstractThe adverse effects of smoking cessation in individuals with mental health disorders have been a point concern, and progress the development treatment has slow. The primary first-line treatments for are Nicotine Replacement Therapy, Bupropion, Varenicline, behavioural support. Nortriptyline Clonidine second-line used when not effective or contraindicated. Smoking medications shown to be reducing nicotine cravings withdrawal symptoms promoting among patients living disorders. However,...
This work aimed at creating a psychosocial intervention based on growth mindset theory and implementation intention strategies, in order to reduce alcohol consumption among users the general population, clinical population of individuals with use disorder. A mixed method approach was used, combining qualitative quantitative research methods both populations. Four focus groups were first conducted extract arguments favor malleable view (study 1A), situations that trigger desire drink alcohol,...
Abstract Aims up to 80% of patients with alcohol use disorder display cognitive impairments. Some studies have suggested that alcohol-related impairments could be worsened by hepatic damage. The primary objective this study was compare mean scores on the Brief Evaluation Alcohol-Related Neurocognitive Impairments measure between (CIR+) or without cirrhosis (CIR−). Methods we conducted a prospective case–control in hepatology department university hospital. All were assessed using...
Introduction Cognitive impairment is a well-recognized key feature of schizophrenia. However, these cognitive impairments may be worsened by alcohol consumption. Up to 80% patients with use disorders (AUD) display impairments. Screening for those full neuropsychological assessment difficult. The Brief Evaluation Alcohol-Related Neuropsychological Impairments (BEARNI) specific tool screening easy implement in clinical practice (Ritz et al. Alcoholism: Clinical and Experimental Research 2015;...
This case report highlights the of a woman from Senegal with PICA disorders switching kaolin substance commonly used in african population, to paper context anxiety disorder.
Introduction Tianeptine is prescribed as an antidepresant in Europe. The prescription drug produced tianeptine sodium. However, it can also be found on the Internet sulfate sold a nootropric. Misuse of sodium has been documented, but there’s little scientific evidence use. Objectives Review use without prescription. Present clinical report Methods PubMed review tienptine Clinical patient using adquiered Internet. Results Systematic search term “tianeptine abuse” conducted 01/10/2022. A total...